Patents by Inventor David Murakami

David Murakami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156816
    Abstract: Described in exemplary embodiments herein are methods, compositions, and kits for diagnosing, prognosing, monitoring, treating and/or preventing a hemopoietic malignancy and/or relapse thereof in a subject. In some embodiments, the methods can include determining an average cellular mass of cells in a sample from the subject and/or detecting one or more molecular signatures in one or more of the cells. In some embodiments, treatment includes administering one or more BCR-ABL tyrosine kinase inhibitors or a pharmaceutical formulation thereof, one or more pre-BCR signaling pathway inhibitors or a pharmaceutical formulation thereof, one or more p38 MAPK inhibitors or a pharmaceutical formulation thereof; or any combination thereof.
    Type: Application
    Filed: December 15, 2023
    Publication date: May 16, 2024
    Inventors: Alexander K. Shalek, Peter Winter, David Weinstock, Mark Murakami, Scott Manalis, Andrew Navia, Jennyfer Galvez-Reyes
  • Patent number: 11920165
    Abstract: Embodiments of the disclosure concern systems, methods, and/or compositions for cultivation of mammalian viruses, including at least human noroviruses and sapoviruses within the Caliciviridae family of viruses. The ex vivo culture systems include intestinal enteroids in combination with bile or a functionally active fraction or component thereof. In specific embodiments, the culture system is utilized to test inactivation compounds for therapeutic or environmental efficacy and to test contaminated comestibles and/or environmental entities for determination of the presence of infectious virus. Furthermore, antiviral compositions may be tested using systems of the disclosure, including drugs, small molecule inhibitors, and biologics such as neutralizing monoclonal antibodies.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: March 5, 2024
    Assignee: Baylor College of Medicine
    Inventors: Mary K. Estes, David Graham, Robert Legare Atmar, Sue Ellen Crawford, Khalil Ettayebi, Kosuke Murakami
  • Patent number: 4195335
    Abstract: A switching regulator type power supply, including a series switching element which, when energized, provides a voltage signal to an averaging filter, the output of which is applied to follow-on inverter and filtering circuits to produce a desired output voltage. In the startup mode of the supply, the switching element is energized by a circuit portion functioning as a blocking oscillator. The control action of the blocking oscillator results in a series of incremental increases in the voltage output of the averaging filter, thus avoiding large startup currents. When the output of the averaging filter reaches a predetermined first level, an error amplifier circuit is initiated, which forces the circuit portion to function as a constant current switched amplifier.
    Type: Grant
    Filed: July 20, 1978
    Date of Patent: March 25, 1980
    Assignee: The Boeing Company
    Inventors: David Murakami, Donald J. Sommer